In this conversation, Rick and Isra cover much ground on psychedelics, from set & setting and preparation and integration to Rick’s best practices, personal LSD, MDMA and psilocybin journeys …
You’re having a VR program that’s supposed to somehow remind you of your own inner imagery, so it will be not as precise as your own imagination. -Rick Doblin Originally appearing here (Archived)
“Australia’s policy change is one that every country should consider: suffering people, regardless of nationality, need more opportunities to access novel treatments,” Rick Doblin, executive director …
“Australia’s policy change is one that every country should consider: suffering people, regardless of nationality, need more opportunities to access novel treatments,” MAPS founder and director Dr. …
After decades of criminalization, Australia’s government said Friday that it will legalize the prescription of MDMA and psilocybin for the treatment of two medical conditions, a historic move hailed …
Summary: “At this moment, when two successful Phase 3 studies of MDMA-assisted therapy for PTSD have brought us closer to potential FDA approval than ever before, MAPS and MAPS PBC must faithfully …
In early January, MAPS announced that MAPP2 met pre-specified primary and key secondary endpoints and that it planned to file a new drug application submission in the third quarter of 2023. At the end …
Summary: Founder and Executive Director of MAPS Rick Doblin discusses a new study that supports the psychedelic MDMA as treatment for PTSD on ‘Kennedy.’ Originally appearing here (Archived) …
Summary: Andrew Huberman, Ph.D., mentions MAPS and MAPS Founder and Executive Director Rick Doblin, Ph.D., while being interviewed by Tom Segura on the 2 Bears, 1 Cave (YMHstudios) podcast at 39 minutes …
Originally appearing here (Archived)
Summary: In a recent New Atlas article, Rich Haridy thoroughly explores the evolution of opinions within the psychedelic community about what ending the drug war could look like. Haridy highlights the …
Summary: Explore the resurgence of psychedelic research, including MAPS-sponsored clinical trials of MDMA-assisted therapy for PTSD, in a new PBS program! Stream on PBS Nova, YouTube, or the PBS Video …
